Therapeutic hybrid prodrug for gut-mediated treatment of cardiovascular diseases
| Institution | Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft (MDC) |
|---|---|
| Project leader | Dominik Müller |
| Site | Berlin |
| Project type | Translational Research Project |
| Funding | € 150.000,00 |
| Begin | 01.06.2025 |
| End | 30.11.2026 |
Förderkennzeichen
81X2100189
Projektnummer
1987